Teva Pharmaceutical Industries Ltd (TEVA):企業の財務・戦略的SWOT分析

◆英語タイトル:Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH33504FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:95
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Teva Pharmaceutical Industries Ltd (TEVA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Teva Pharmaceutical Industries Ltd (Teva) discovers, develops, manufactures and commercializes generic and specialty medicines. It provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company offers generic medicines in a range of dosage forms including capsules, tablets, injectables, liquids, inhalants, creams and ointments. Teva also provides over-the-counter (OTC) products, besides active pharmaceutical ingredients (APIs). It is currently focusing on developing new generic drugs. The company conducts its worldwide operations through a network of global subsidiaries. Teva is headquartered in Petach Tikva, Israel.

Teva Pharmaceutical Industries Ltd Key Recent Developments

Mar 01,2021: Teva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance Conference
Feb 10,2021: Teva reports fourth quarter and full year 2020 financial results
Feb 03,2021: Karo Pharma acquires European OTC brand portfolio from Teva Pharmaceuticals
Jan 27,2021: Teva takes data-driven decision-making to next level with Genedata Biologics
Jan 12,2021: Teva sets ambitious long-term environmental goals as part of renewed ESG Strategy

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Teva Pharmaceutical Industries Ltd – Key Facts
Teva Pharmaceutical Industries Ltd – Key Employees
Teva Pharmaceutical Industries Ltd – Key Employee Biographies
Teva Pharmaceutical Industries Ltd – Major Products and Services
Teva Pharmaceutical Industries Ltd – History
Teva Pharmaceutical Industries Ltd – Company Statement
Teva Pharmaceutical Industries Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Teva Pharmaceutical Industries Ltd – Business Description
Geographical Segment: Europe
Target Markets
Performance
Overview
Geographical Segment: International Markets
Target Markets
Performance
Geographical Segment: North America
Target Markets
Performance
Overview
R&D Overview
Teva Pharmaceutical Industries Ltd – Corporate Strategy
Teva Pharmaceutical Industries Ltd – SWOT Analysis
SWOT Analysis – Overview
Teva Pharmaceutical Industries Ltd – Strengths
Teva Pharmaceutical Industries Ltd – Weaknesses
Teva Pharmaceutical Industries Ltd – Opportunities
Teva Pharmaceutical Industries Ltd – Threats
Teva Pharmaceutical Industries Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Teva Pharmaceutical Industries Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 01, 2021: Teva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance Conference
Feb 10, 2021: Teva reports fourth quarter and full year 2020 financial results
Jan 27, 2021: Teva takes data-driven decision-making to next level with Genedata Biologics
Jan 12, 2021: Teva sets ambitious long-term environmental goals as part of renewed ESG Strategy
Nov 05, 2020: Teva reports third quarter 2020 financial results
Aug 25, 2020: Statement in response to news of the Indictment of Teva USA
Aug 05, 2020: Teva enters biosimilar commercialisation partnership with Alvotech
Aug 05, 2020: Teva reports second quarter 2020 financial results
Aug 04, 2020: Teva Pharmaceutical Industries announces board change
Jul 31, 2020: Teva-Takeda joint venture divests certain assets in Japan to Nichi-Iko
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Teva Pharmaceutical Industries Ltd, Key Facts
Teva Pharmaceutical Industries Ltd, Key Employees
Teva Pharmaceutical Industries Ltd, Key Employee Biographies
Teva Pharmaceutical Industries Ltd, Major Products and Services
Teva Pharmaceutical Industries Ltd, History
Teva Pharmaceutical Industries Ltd, Subsidiaries
Teva Pharmaceutical Industries Ltd, Joint Venture
Teva Pharmaceutical Industries Ltd, Key Competitors
Teva Pharmaceutical Industries Ltd, Ratios based on current share price
Teva Pharmaceutical Industries Ltd, Annual Ratios
Teva Pharmaceutical Industries Ltd, Annual Ratios (Cont...1)
Teva Pharmaceutical Industries Ltd, Annual Ratios (Cont...2)
Teva Pharmaceutical Industries Ltd, Interim Ratios
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Teva Pharmaceutical Industries Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Teva Pharmaceutical Industries Ltd (TEVA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Immunovia AB (IMMNOV):製薬・医療:M&Aディール及び事業提携情報
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • China High Speed Transmission Equipment Group Co Ltd (658):電力:M&Aディール及び事業提携情報
    Summary China High Speed Transmission Equipment Group Co Ltd (CHSTE), a subsidiary of Five Seasons XVI Ltd, specializes in the production of high-speed and heavy-load transmission equipment. The company carries out research, design, development, manufacture and distribution of a broad range of mecha …
  • Starbucks Corp (SBUX):企業の財務・戦略的SWOT分析
    Starbucks Corp (SBUX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Omnicom Group Inc. (OMC):企業の財務・戦略的SWOT分析
    Omnicom Group Inc. (OMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Grupo Aval Acciones y Valores S.A.:戦略・SWOT・企業財務分析
    Grupo Aval Acciones y Valores S.A. - Strategy, SWOT and Corporate Finance Report Summary Grupo Aval Acciones y Valores S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Top Kinisis Travel Public Ltd:企業の戦略・SWOT・財務情報
    Top Kinisis Travel Public Ltd - Strategy, SWOT and Corporate Finance Report Summary Top Kinisis Travel Public Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cogentix Medical Inc (CGNT):医療機器:M&Aディール及び事業提携情報
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc is a medical device company that offers patient care products. The company offers products such as macroplastique, PrimeSight, urgent pc and ptq products, among others. Its products are used in critical care, faecal incont …
  • Hugo Boss AG (BOSS):企業の財務・戦略的SWOT分析
    Hugo Boss AG (BOSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • William Demant Holding AS (WDH)-医療機器分野:企業M&A・提携分析
    Summary William Demant Holding A/S (WDH) develops, manufactures and distributes products and equipment designed to aid people with hearing loss in their individual communication. Its major areas of focus include hearing devices, hearing implants, diagnostic instruments and personal communication dev …
  • Isetan Mitsukoshi Holdings Ltd (3099):企業の財務・戦略的SWOT分析
    Isetan Mitsukoshi Holdings Ltd (3099) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • AF Gruppen ASA (AFG):企業の財務・戦略的SWOT分析
    AF Gruppen ASA (AFG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Olympus Corporation:企業の戦略・SWOT・財務分析
    Olympus Corporation - Strategy, SWOT and Corporate Finance Report Summary Olympus Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Begbies Traynor Group plc (BEG):企業の財務・戦略的SWOT分析
    Summary Begbies Traynor Group plc (BTG) is a business and consultancy service provider. The company offers professional services such as business rescue options, advisory options, forensic accounting and investigations, corporate and commercial finance, personal insolvency solutions and services. It …
  • Kalvista Pharmaceuticals Inc (KALV):医療機器:M&Aディール及び事業提携情報
    Summary Kalvista Pharmaceuticals Inc (Kalvista), formerly Carbylan Therapeutics Inc, is a pharmaceutical company that discovers, develops and commercializes small molecule protease inhibitors. The company’s product candidates are inhibitors of plasma kallikrein, which is being developed for heredita …
  • Canada Pension Plan Investment Board:戦略・SWOT・企業財務分析
    Canada Pension Plan Investment Board - Strategy, SWOT and Corporate Finance Report Summary Canada Pension Plan Investment Board - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Orchid Pharma Ltd (ORCHIDPHAR):企業の財務・戦略的SWOT分析
    Summary Orchid Pharma Ltd (Orchid), formerly Orchid Chemicals & Pharmaceuticals Ltd is a pharmaceutical company that develops and manufactures pharmaceutical solutions such as formulations and API products. The company offers formulations such as cardiovascular products, neuropsychiatry products, an …
  • Extraction Oil & Gas Inc (XOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Extraction Oil & Gas Inc (Extraction Oil & Gas), formerly known as Extraction Oil & Gas LLC, is an independent upstream oil and gas company which focuses on the acquisition, development and production of oil, natural gas and natural gas liquids reserves in the Rocky Mountains. The company pr …
  • National Gas & Industrial Co. (2080):企業の財務・戦略的SWOT分析
    National Gas & Industrial Co. (2080) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sa Sa International Holdings Limited (178):企業の財務・戦略的SWOT分析
    Sa Sa International Holdings Limited (178) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • RXi Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向
    RXi Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RXi Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆